Amy Schulman

Amy Schulman

Fortune : 7 M $ au 31/05/2026

65 ans
Health Technology
Commercial Services
Health Services

Profil

Amy L.
Schulman
founded Lyndra Therapeutics, Inc. in 2015, where she is working as Executive Chairman from 2019 and LS Polaris Innovation Fund in 2017, where she is working as Managing Partner from 2017.
Ms. Schulman also founded Suono Bio, Inc., where she worked as Executive Chairman.
Ms. Schulman also currently works at SQZ Biotechnologies Co., as Chairman from 2015, Alnylam Pharmaceuticals, Inc., as Chairman from 2023, Elevance Health, Inc., as Independent Director from 2026, and various other companies.
Ms. Schulman also formerly worked at Eagle Biologics, Inc., as Chief Executive Officer from 2014 to 2016, Olivo Laboratories LLC, as Executive Chairman & Chief Executive Officer, Fractyl Health, Inc., as Independent Director from 2018 to 2025, and various other companies.
Ms. Schulman received her undergraduate degree from Wesleyan University and graduate degree in 1989 from Yale Law School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/05/2026 23 211 ( 0,02 % ) 7 M $ 31/05/2026
13/05/2026 781 ( 0 % ) 307 081 $ 31/05/2026

Postes actifs de Amy Schulman

SociétésPosteDébut
ALNYLAM PHARMACEUTICALS, INC. Président 05/01/2023
SQZ BIOTECHNOLOGIES COMPANY Président 01/07/2015
HUDSON EXECUTIVE INVESTMENT CORP. II Directeur/Membre du Conseil 25/01/2021
ELEVANCE HEALTH, INC. Directeur/Membre du Conseil 12/01/2026
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 20/11/2019
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Amy Schulman

SociétésPosteFin
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Amy Schulman

Formation de Amy Schulman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

45

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées45

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Producer Manufacturing

Health Technology

Health Services

Commercial Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Consumer Non-Durables

Consumer Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Finance

Health Services

Health Technology

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Amy Schulman
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇